The effect of peroxisome-proliferator-activated receptor-α on the activity of the cholesterol 7α-hydroxylase gene

被引:68
|
作者
Patel, DD
Knight, BL
Soutar, AK
Gibbons, GF
Wade, DP
机构
[1] Hammersmith Hosp, Ctr Clin Sci, MRC, Lipoprot Grp, London W12 0NN, England
[2] Radcliffe Infirm, Nuffield Dept Clin Med, Metab Res Lab, Oxford OX2 6HE, England
关键词
diurnal rhythm; gene promoter; PPAR alpha-null mice; transcription;
D O I
10.1042/0264-6021:3510747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cholesterol 7 alpha -hydroxylase (Cyp7a1) plays a central role in the regulation of bile acid and cholesterol metabolism, and transcription of the gene is controlled by bile acids and hormones acting through a complex interaction with a number of potential steroid-hormone-binding sites. Transcriptional activity of the human CYP7A1 gene promoter transfected into HepG2 cells was decreased in a concentration-dependent manner by co-transfection with an expression vector for peroxisome-proliferator-activated receptor-alpha (PPAR alpha). This effect was augmented by 9-cis-retinoic acid receptor-alpha (RXR alpha) and activators of PPAR alpha to give a maximum inhibition of approx. 80 %. The region responsible for this inhibition contained a site known to bind hepatocyte nuclear factor 3 (HNF4), and mutation of this site greatly decreased the effect. Co-expression of HNF4 increased promoter activity and decreased the effect of PPAR alpha. Gel-mobility-shift assays failed to detect any binding of PPAR alpha /RXR alpha dimers to any regions of the promoter containing potential binding sites. Also the hepatic abundance of Cyp7a1 mRNA in mice in which the PPAR alpha gene was disrupted was the same as in normal mice, both during the dark phase, when the animals were feeding, and during the light phase, when mRNA abundance was greatly increased. Cholesterol feeding produced the same increase in hepatic Cyp7a1 mRNA abundance in PPAR alpha -null animals as in normals. It is concluded that, whereas PPAR alpha can affect CYP7A1 gene transcription in vitro through an indirect action, probably by competing for cofactors, this is unlikely to be a major influence on Cyp7a1 activity under normal physiological conditions.
引用
收藏
页码:747 / 753
页数:7
相关论文
共 50 条
  • [21] Peroxisome-proliferator-activated receptor (PPAR)-γ activation stimulates keratinocyte differentiation
    Mao-Qiang, M
    Fowler, AJ
    Schmuth, M
    Lau, P
    Chang, S
    Brown, BE
    Moser, AH
    Michalik, L
    Desvergne, B
    Wahli, W
    Li, M
    Metzger, D
    Chambon, PH
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02) : 305 - 312
  • [22] Synergistic effect of peroxisome proliferator activated receptor-γ and liver X receptor-α in the regulation of inflammation in macrophages
    Piraino, Giovanna
    Cook, James A.
    O'Connor, Michael
    Hake, Paul W.
    Burroughs, Timothy J.
    Teti, Diana
    Zingarelli, Basilia
    SHOCK, 2006, 26 (02): : 146 - 153
  • [23] Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway
    Wang, Zhen
    Yang, Shu
    Li, Yan
    Zhou, Yongying
    Liu, Daoquan
    Liu, Jianmin
    DiSanto, Michael E.
    Zhang, Xinhua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [24] Peroxisome proliferator-activated receptor-γ gene polymorphisms and Crohn's disease
    Leung, Euphemia
    Hong, Jiwon
    Fraser, Alan G.
    Merriman, Tony R.
    Vishnu, Prakash
    Krissansen, Geoffrey W.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (04) : 453 - 454
  • [25] Peroxisome proliferator activated receptor-γ and traumatic brain injury
    Qi, Lei
    Jacob, Asha
    Wang, Ping
    Wu, Rongqian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (04): : 283 - 292
  • [26] Peroxisome proliferator-activated receptor-α -: Friend or foe?
    Yagil, Chana
    Yagil, Yoram
    HYPERTENSION, 2007, 50 (05) : 847 - 850
  • [27] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [28] Peroxisome proliferator-activated receptor-γ in the renal mesangium
    Hsueh, WA
    Nicholas, SB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02): : 191 - 195
  • [29] Peroxisome proliferator activated receptor-α expression in human liver
    Palmer, CNA
    Hsu, MH
    Griffin, KJ
    Raucy, JL
    Johnson, EF
    MOLECULAR PHARMACOLOGY, 1998, 53 (01) : 14 - 22
  • [30] Regulation of peroxisome proliferator activated receptor-γ in rat pituitary
    Nogueiras, R
    Caminos, JE
    Gallego, R
    Raghay, K
    Bravo, S
    Tovar, S
    Pombo, C
    López, M
    Tena-Sempere, M
    García-Caballero, T
    Diéguez, C
    JOURNAL OF NEUROENDOCRINOLOGY, 2005, 17 (05) : 292 - 297